Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas

Cancer Science

Volumn 106, Issue 7, 2015, Pages 840-847

  Kaneko, Yoshiki ^a   Suenaga, Yusuke ^a,b   Islam, S M Rafiqul ^a,d   Matsumoto, Daisuke ^a   Nakamura, Yohko ^a   Ohira, Miki ^c   Yokoi, Sana ^b   Nakagawara, Akira ^a,e  

^a Division of Biochemistry and Innovative Cancer Therapeutics and Children's Cancer Research Center   (Japan)

^b Cancer Genome Center   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^e Saga Medical Center KOSEIKAN   (Japan)

Author keywords

MYCN; NCYM; Neuroblastoma; OCT4; Transcriptional regulation

Indexed keywords

CD133 ANTIGEN; KRUPPEL LIKE FACTOR 4; LIN28 PROTEIN; MESSENGER RNA; MYC PROTEIN; MYCN PROTEIN; NCYM PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOPROTEIN; PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; MYCN PROTEIN, HUMAN; NCYM PROTEIN, HUMAN; NUCLEAR PROTEIN; POU5F1 PROTEIN, HUMAN; TUMOR PROTEIN;

AGGRESSIVENESS; ARTICLE; ASYMMETRIC CELL DIVISION; BINDING SITE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; CELL RENEWAL; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DOWN REGULATION; E BOX ELEMENT; ENHANCER REGION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; INTRON; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STABILITY; REGULATOR GENE; TUMOR GROWTH; TUMOR VOLUME; ADRENAL TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; INFANT; KAPLAN MEIER METHOD; METABOLISM; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADRENAL GLAND NEOPLASMS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; NEOPLASM PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; ONCOGENE PROTEINS; PROGNOSIS;

EID: 84936985363     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12677     Document Type: Article

References (28)

1. Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013; 13: 397-411.
2. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121-4.
3. Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997; 16: 2985-95.
4. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008; 22: 2755-66.
5. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8: 976-90.
6. Suenaga Y, Islam SM, Alagu J et al. NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3beta resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet 2014; 10: e1003996.
7. Suenaga Y, Kaneko Y, Matsumoto D, Hossain MS, Ozaki T, Nakagawara A. Positive auto-regulation of MYCN in human neuroblastoma. Biochem Biophys Res Commun 2009; 390: 21-6.
8. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-16.
9. Pezzolo A, Parodi F, Marimpietri D et al. Oct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells. Cell Res 2011; 21: 1470-86.
10. Molenaar JJ, Domingo-Fernandez R, Ebus ME et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet 2012; 44: 1199-206.
11. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, Biedler JL. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 1995; 6: 449-56.
12. Hammerle B, Yanez Y, Palanca S et al. Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor. PLoS One 2013; 8: e76761.
13. Ohira M, Oba S, Nakamura Y et al. Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. Cancer Cell 2005; 7: 337-50.
14. Cotterman R, Knoepfler PS. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS One 2009; 4: e5799.
15. Niwa H. How is pluripotency determined and maintained? Development 2007; 134: 635-46.
16. Izumi H, Kaneko Y. Evidence of asymmetric cell division and centrosome inheritance in human neuroblastoma cells. Proc Natl Acad Sci U S A 2012; 109: 18048-53.
17. Westermann F, Muth D, Benner A et al. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol 2008; 9: R150.
18. Shum CK, Lau ST, Tsoi LL et al. Kruppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation. Oncogene 2013; 32: 4086-99.
19. Kim J, Woo AJ, Chu J et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010; 143: 313-24.
20. Young RA. Control of the embryonic stem cell state. Cell 2011; 144: 940-54.
21. Chambers I, Colby D, Robertson M et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113: 643-55.
22. Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341: 1165-73.
23. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-8.
24. Boyer LA, Lee TI, Cole MF et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122: 947-56.
25. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-6.
26. Kotkamp K, Kur E, Wendik B et al. Pou5f1/Oct4 promotes cell survival via direct activation of mych expression during zebrafish gastrulation. PLoS One 2014; 9: e92356.
27. Chen S, Zhang YE, Long M. New genes in Drosophila quickly become essential. Science 2010; 330: 1682-5.
28. Reinhardt JA, Wanjiru BM, Brant AT, Saelao P, Begun DJ, Jones CD. De novo ORFs in Drosophila are important to organismal fitness and evolved rapidly from previously non-coding sequences. PLoS Genet 2013; 9: e1003860.